Cord blood and tissue banking service provider, Babycell, a division of RMS Regrow today announced an aggressive expansion plan for Andhra Pradesh. “To create focused services and offer more citizens access to cord blood banking services, the company has decided to expand its operations. Babycell will leverage its experience and expertise to enhance the range and quality of Cord Blood Banking in Hyderabad, Secunderabad , Vijayawada, Vishakhapatnam, Tirupathi, Nizamabad’, said Dr Satyen Sanghavi, CSO, Babycell in a release here. “We have currently tied up with more than 20 hospitals in Hyderabad,” Dr Sanghavi said and added the stem cell industry in India was a disaggregated affair with stem cell service providers only operating within the larger metros. Babycell aims to change the way parents access cord blood banking by making it available to expectant parents nationwide. He said when a child is born, most parents do not have the foresight to plan for any health concerns that the child may face at a later stage in their life. It was important to educate expecting parents that the decision to bank your child’s umbilical cord blood stem cells is crucial as the opportunity to do so is only at the time of birth.
The regenerative medicine field is the new frontier in medicine where scientists and clinicians alike are agreeing that the stem cells found in cord blood are one of the most promising sources for cellular therapy. Cord blood transplants have been performed for patients with genetic or metabolic diseases and have the capability to treat more than 80 diseases. While talking on stem cell therapy’s role in gynaecology, Dr Vijayalakshimi, Consultant Gynaecologist and Medical Geneticist, at Vasavi Medical & Research Centre said ‘The use of umbilical cord blood stem cells has increased significantly in the past 20 years. Today, doctors all over the world are realising the power of newborn stem cells and recommending family banking to their patients, Dr Vijayalakshmi said.